Literature DB >> 567638

Antibiotics from Basidiomycetes. V merulidial, a new antibiotic from the Basidiomycete Merulius tremellosus Fr.

W Quack, T Anke, F Oberwinkler, B M Giannetti, W Steglich.   

Abstract

Merulidial, a new antibiotic, was isolated from the culture fluid of the Basidiomycete Merulius tremellosus Fr., strain No. WQ 568. Merulidial inhibits a variety of bacteria and fungi. In cells of the ascitic form of EHRLICH carcinoma, DNA synthesis is inhibited at lower concentration as compared to RNA and protein synthesis. Merulidial shows mutagenicity when incubated with the his-mutant TA 100 for Salmonella typhimurium (B.N.AMES). The molecular formula as determined by high resolution mass spectrometry is C15H20O3.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567638     DOI: 10.7164/antibiotics.31.737

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  The stimulation of capsaicin-sensitive neurones in a vanilloid receptor-mediated fashion by pungent terpenoids possessing an unsaturated 1,4-dialdehyde moiety.

Authors:  A Szallasi; M Jonassohn; G Acs; T Bíró; P Acs; P M Blumberg; O Sterner
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 2.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

3.  Hog1p activation by marasmic acid through inhibition of the histidine kinase Sln1p.

Authors:  Stefan Jacob; Anja Schüffler; Eckhard Thines
Journal:  Pest Manag Sci       Date:  2016-03-22       Impact factor: 4.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.